(19)

(11)

EP 4 561 528 A1

(12)

(43) Date of publication: 04.06.2025 Bulletin 2025/23 (21) Application number: 23749079.2 (22) Date of filing: 31.07.2023

(51) International Patent Classification (IPC):  A61K 9/00(2006.01) A61K 47/18(2017.01) A61K 9/08(2006.01) A61K 31/137(2006.01) A61P 25/26(2006.01) A61K 47/20(2006.01) (52) Cooperative Patent Classification (CPC): A61K 9/0095; A61K 47/183; A61K 47/20; A61K 9/08; A61P 25/26; A61K 31/165 (86) International application number: PCT/EP2023/071211 (87) International publication number: WO 2024/023367 (01.02.2024 Gazette 2024/05)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: KH MA MD TN (30) Priority: 29.07.2022 EP 22386051 (71) Applicants: LABOMED PHARMACEUTICAL COMPANY S.A. 19441 Koropi, Attica (GR) Adalvo Limited San Gwann, SGN 3000 (MT)	(72) Inventors: LIOLIOS, Georgios 15232 Chalandri Attica (GR) PSARRAKIS, Ioannis 19500 Lavrion (GR) (74) Representative: Roukounas, Dimitrios  c/o Regus Business Center Nymphenburger Straße 4 80335 München 80335 München (DE)